It complicates when we talk about it as if it was something new, because they don't regard it as innovation. So, they see the Brazilian pharmaceutical industry clearly as a replica industry. And being a replica industry, it's not in the same level of others to discuss about innovation. A similar ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login